Cargando...
13.1 ENDOCANNABINOID MODULATION OF DOPAMINE NEUROTRANSMISSION
BACKGROUND: Dopamine is the major neurotransmitter implicated in schizophrenia pathology. Thus, understanding the processes modulating dopaminergic signalling may lead to new insights in the biology and treatment of this disorder. The endocannabinoids anandamide and 2-arachidonoylglicerol (2-AG) mod...
Gardado en:
| Publicado en: | Schizophr Bull |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5888798/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby014.049 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|